Patent details

Basic Information

Publication number:

EP1935427

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP080013402

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Uses of soluble CTLA4 mutant molecules

French Title of Invention:

Utilisations des molécules mutantes solubles CTLA4

German Title of Invention:

Verwendung von löslichen mutanten CTLA4-Mutantenmolekülen

SPC Number:

Dates

Filing date:

02/07/2001

Grant date:

07/03/2018

EP Publication Date:

25/06/2008

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/03/2018

EP B1 Publication Date:

07/03/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

02/07/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/02/2018

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

1

Name:

MARKS & CLERK LLP

From:

12/08/2022

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

2

Name:

MARKS & CLERK LLP

From:

22/03/2018

Address:

B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

12/08/2022

Inventor

1

Name:

Becker, Jean-Claude

Address:

United States (US)

2

Name:

Cohen, Robert

Address:

United States (US)

3

Name:

Carr, Suzette

Address:

United States (US)

4

Name:

Hagerty, David

Address:

United States (US)

5

Name:

Peach, Robert, J.

Address:

United States (US)

Priority

Priority Number:

215913 P

Priority Date:

03/07/2000

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/17; A61K 45/06; A61P 19/02; A61P 37/04;

Publication

European Patent Bulletin

1

Issue number:

201810

Publication date:

07/03/2018

Description:

Grant (B1)

2

Issue number:

201814

Publication date:

04/04/2018

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/06/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
05/04/2018	Outgoing Correspondence	1
22/03/2018	Power Of Attorney	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56